Discussion.~~~~~~~S imulated SAH,4 hypothalamic stimulation,1' and parenteral administration of catecholamines5 in animals produce necrotic myocardial lesions, which may be prevented by severing the cord at C2 level or by administering reserpine or propranolol.4 A possible effect of the hypothalamic lesions after a SAH12 is to produce an abnormal reaction of the autonomic nervous system resulting in persistantly high excretion rates of urinary catecholamines.2 The close association between the hypothalamus and the autonomic nervous system, coupled with the high correlation between hypothalamic and myocardial lesions after SAH,13 points to a catecholamine-linked origin of the myocardial necrosis.The pathological results of this study should be interpreted in the light of results (unpublished) of a recent survey, which showed that out of 54 patients who died of SAH at the Southeast Thames regional neurosurgical unit, 49 had hypothalamic lesions similar to those found in this study and 42 of these patients (78% of the whole) had necrotic myocardial lesions. Thus the fact that in our study all six patients who died in the drug-treated group had "clean hearts" (with normal ECGs) while all six in the placebo-treated group had focal necrotic myocardial lesions (and abnormal ECGs) becomes important. Due to the probable absence of alpha-receptors in the myocardium"4 we presume that propranolol rather than phentolamine was the agent responsible.What are the clinical implications of these results ? Excessive amounts of catecholamines may induce heart failure, as in the cardiomyopathy associated with phaeochromocytomas."5 Some other types of congestive cardiomyopathy may well result from an abnormal interaction between catecholamines and the myocardium and benefit from beta-blockade.16 A recent report'7 described such a cardiomyopathy, which was cured by stopping treatment with ephedrine. Some authors consider that catecholamines play a crucial part in the onset of myocardial infarction,'8 thus suggesting an explanation for the protective effect of beta-blockade on the ischaemic myocardium. Despite its "cardioprotective effect," propranolol did not influence mortality in cases of SAH and accompanying myocardial damage. This is because lethal secondary events such as a second SAH are not critically influenced by propranolol or phentolamine, though the results of this preliminary study suggest a possible protective action of these two drugs with regard to cerebrovascular spasm. In other "stress areas" with associated myocardial necrotic lesions and unstable cardiac rhythms, such as head injuries,7 beta-blockade may have an important role. The source of hearts for cardiac transplantation is another important, though perhaps more remote, factor to be considered. If, as is often the case, the donor has died after a cerebrovascular accident or head injury then early administration of a beta-blocker to the potential donor might be wise.We would like to thank Dr D M Burley of Ciba Laboratories for supplying the phentolamine for the...